Premature progesterone rise incidence & its effects on in vitro fertilization cycles

OM Abiodun; AO Omobuwa; AG Fakunle; VT Oluwagbaye; MO Komolafe; O Adewale; AA Akindele; AO Fasanu; JO Komolafe

doi:10.4314/rejhs.v11i1.1

Authors

OM Abiodun
AO Omobuwa
AG Fakunle
VT Oluwagbaye
MO Komolafe
O Adewale
AA Akindele
AO Fasanu
JO Komolafe https://orcid.org/0009-0003-9414-5082

DOI:

https://doi.org/10.4314/rejhs.v11i1.1

Keywords:

ovarian stimulation, premature progesterone rise, IVF outcomes

Abstract

Background: Ovarian stimulation using gonadotropins is associated with premature progesterone rise (PPR) in late follicular phase compared to natural cycle. Two schools of thoughts exist concerning implications of PPR during late follicular phase with one insisting that outcome of in vitro fertilization (IVF) is adversely affected when PPR occurs while the second school of thought argues that PPR has no adverse effect on IVF outcome. The study is aimed at determining the incidence of PPR in the cohort data evaluated; pregnancy rates across the sides of adopted cut-off level of progesterone and association if any between PPR & pregnancy rates.

Methods: It was a descriptive retrospective cohort study of data of 114 patients and egg donors. Analysis of continuous & categorical data was done using IBM SPSS Statistics 25.

Results: Mean serum progesterone on HCG day of IVF cycle among the cohort was 2.490±1.355 with a PPR incidence of 55%. The odds of having PPR was 6.7 times higher among subjects with follicular number more than 13 compared to subjects with follicular numbers ≤13 . Number of follicles retrieved & age of subjects were strongly associated with progesterone level. The odds of subject with PPR getting pregnant was found to be 1.5 times less compared to the subjects with pre-HCG P4 < 1.5ng/ml.

Conclusion: Pre-HCG progesterone level is positively associated with pregnancy outcome in IVF cycles

References

Elnashar AM. Progesterone rise on the day of HCG administration (premature luteinization) in IVF: an overdue update. Journal of assisted reproduction and genetics. 2010 Apr;27(4):149-55

Bosch E, Valencia I, Escudero E, Crespo J, Simoìn C, Remohýì J, et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril (2003) 80:1444–9. doi: 10.1016/j.fertnstert.2003.07.002

Younis JS, Simon A, Laufer N. Endometrial preparation: lessons from oocyte donation. Fertil Steril. 1996;66:873–84

Givens CR, Schriock ED, Dandekar PV, et al. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles. Fertil Steril. 1994;62:1011–7.

Ubaldi F, Albano C, Peukert M, et al. Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles. Hum Reprod. 1996;11:1405–7.

Sims A, Seltman HJ, Muasher SJ. Early follicular rise of serum progesterone concentration in response to a flare-up effect of gonadotrophin- releasing hormone agonist impairs follicular recruitment for in-vitro fertilization. Hum Reprod. 1994;9:235

Edelstein MC, Seltman HJ, Cox BJ, et al. Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone suppression are not predictive of pregnancy outcome. Fertil Steril. 1990;54:853–7.

Hofmann GE, Bentzien F, Bergh PA, et al. Premature luteinization in controlled hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil Steril. 1993;60:675–9.

Silverberg KM, Martin M, Olive DL, et al. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration in in vitro fertilization cycles do not adversely affect embryo quality. Fertil Steril. 1994;61:508–13.

Ou YC, Lan KC, Chang SY, Kung FT, Huang FJ. Increased progesterone/estradiol ratio on the Day of hcg administration adversely affects Success of in vitro fertilization–embryo Transfer in patients stimulated with Gonadotropin-releasing hormone agonist and Recombinant follicle-stimulating h o r m o n e Ta i w a n . J O b s t e t G y n e c o l . 2008;47:168–74.

Ubaldi F, Smitz J, Wisanto A, et al. Oocyte and embryo quality as well as pregnancy rate in intracytoplasmic sperm injection are not affected by high follicular phase serum progesterone. Hum Reprod. 1995;10:3091–6.

Bustillo M, Stern JJ, Coulam CB. Serum progesterone at the time of human chorionic gonadotrophin does not predict pregnancy in in-vitro fertilization and embryo transfer. Hum Reprod. 1995;10:2862–7.

Doldi N, Marsiglio E, Destefani A, et al. Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome. Hum Reprod. 1999;14:601–5.

Lindheim SR, Cohen MA, Chang PL, et al. Serum progesterone before and after human chorionic gonadotropin injection depends on the estradiol response to ovarian hyperstimulation during in vitro fertilization—embryo transfer cycles. J Assist Reprod Genet. 1999;16:242–6.

Silverberg KM, Burns WN, Olive DL, et al. Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. J Clin Endocrinol Metab. 1991;73:797–803.

Mio Y, Terakawa N. Reduced implantation rate associated with a subtle rise in serumprogesterone concentration during the follicular phase of cycles stimulated with a combination of gonadotrophin-releasing hormone agonist and gonadotrophin. Hum Reprod. 1995;10:1060–4.

Schoolcraft W, Sinton E, Schlenker T, et al. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril. 1991;55:563–6.

Kagawa T, Yamano S, Nishida S, et al. Relationship among serum levels of luteinizing hormone, estradiol, and progesterone during follicle stimulation and results of in vitro fertilization and embryo transfer (IVF–ET). J Assist Reprod Genet. 1992;9:106–12.

Ozcakir HT, Levi R, Tavmergen E, Goker EN. Premature luteinization defined as progesterone estradiol ratio >1 on hCG administration day seems to adversely affect clinical outcome in long gonadotropin-releasing hormone agonist cycles. J Obstet Gynaecol Res. 2004;30:100–4.

Hofmann GE, Khoury J, Johnson CA, et al. Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization embryo transfer has no impact on pregnancy outcome. Fertil Steril. 1996;66:980–6.

Martinez F, Coroleu B, Clua E, et al. Serum progesterone concentrations on the day of HCG administration cannot predict pregnancy in assisted reproduction cycles. Reprod Biomed Online. 2004;8:183–90

Sangisapu S, Karunakaran S. Comparative study of serum progesterone levels at the time of human chorionic gonadotropin trigger and ovum pickup in predicting outcome in fresh in vitro fertilization cycles. J Hum Reprod Sci 2019;12:234-9

Huang CC, Lien YR, Chen HF, Chen MJ, Shieh CJ, Yao YL, Chang CH, Chen SU, Yang YS. The duration of pre-ovulatory serum progesterone elevation before hCG administration affects the o u t c o m e o f I V F / I C S I c y c l e s . H u m a n reproduction. 2012 Jul 1;27(7):2036-45.

Venetis CA, Kolibianakis EM, Bosdou JK, Lainas GT, Sfontouris IA, Tarlatzis BC, Lainas TG. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles. Human reproduction. 2015 Mar 1;30(3):684-91.

Christos A. Venetis, Basil C. Tarlatzis. Trying to define the optimal progesterone elevation cut-off in fresh in vitro fertilization cycles: time to evolve our way of thinking Fertility and Sterility, 2018 ; 110 (4): 634-635.

Ashmita J, Vikas S, Swati G. The impact of progesterone level on day of hCG injection in IVF cycles on clinical pregnancy rate. J Hum Reprod Sci 2017;10:265-70.

De Cesare R, Morenghi E, Cirillo F, Ronchetti C,Canevisio V, Persico P, Baggiani A, Sandri MT, Levi-Setti PE. The role of hCG triggering progesterone levels: a real-world retrospective cohort study of more than 8000 IVF/ICSI cycles. Frontiers in Endocrinology. 2020 Sep 23;11:547684.

Merviel P, Bouée S, Jacamon AS, Chabaud JJ, Le Martelot MT, Roche S, Rince C, Drapier H, Perrin A, Beauvillard D. Progesterone levels on the human chorionic gonadotropin trigger day affect the pregnancy rates for embryos transferred at different stages of development in both general and selected IVF/ICSI populations. BMC Pregnancy and Childbirth. 2021 Dec;21(1):1-5.